Quarterly report pursuant to Section 13 or 15(d)

WARRANTS

v3.19.3.a.u2
WARRANTS
9 Months Ended
Dec. 31, 2019
WARRANTS  
WARRANTS

12.     WARRANTS

The following is a continuity schedule of the Company’s common share purchase warrants:

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Number of

 

Exercise Price 

 

    

 Warrants

    

($)

Outstanding and exercisable, March 31, 2018 and December 31, 2018

 

365,974

 

53.19

Issued in connection with anti-dilution provision connected  warrant transaction

 

67,952

 

55.71

Issued in connection with anti-dilution provision connected  warrant transaction

 

6,305

 

34.50

Issued in connection with anti-dilution provision connected  warrant transaction

 

52,590

 

38.91

Expired

 

(204,304)

 

(51.85)

Outstanding and exercisable, March 31, 2019

 

288,517

 

40.27

Expired

 

(163,483)

 

(38.91)

Outstanding and exercisable, December 31, 2019

 

125,034

 

20.07

 

During the nine months ended December 31, 2019, 163,483 warrants expired in accordance with their terms (December 31, 2018 – Nil)

Common share purchase warrants

The following is a summary of common share purchase warrants outstanding as of December 31, 2019.

 

 

 

 

 

 

Exercise 

    

Number of 

    

 

Price ($)

 

Warrants

 

Expiry Date

90.00

 

15,658

 

March 31, 2023

37.50

 

2,667

 

June 27, 2020

9.375

 

64,025

 

August 14, 2022

9.375

 

42,684

 

March 31, 2022

 

 

125,034

 

 

 

The weighted-average remaining contractual term of the outstanding warrants was 2.53 years (March 31, 2019 – 1.51 years).